Elevance Health, Inc.
DE ˙ XTRA
333,90 € ↓ -10,80 (-3,13%)
2026-06-03
DEL PRIS
SecurityDE:A58 / Elevance Health, Inc.
InstitutionTcw Group Inc
Latest Disclosed Ownership3,668 shares
Latest Disclosed Value $ 1,073,807
Tcw Group Inc reports 24.68% decrease in ownership of A58 / Elevance Health, Inc.

On May 14, 2026 - Tcw Group Inc filed a 13F-HR form disclosing ownership of 3,668 shares of Elevance Health, Inc. (DE:A58) valued at $910,764 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 4,870 shares of Elevance Health, Inc.. This represents a change in shares of -24.68% during the quarter. The current value of the position is $1,224,745 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 3,668 -1,202 -24.68 1,074 -37.14 0.0043
2026-02-17 2025-12-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 4,870 4,870 1,707 0.0122
2025-11-14 2025-09-30 13F ELEVANCE HEALTH COM 036752103 0 -14,411 -100.00 0 -100.00
2025-08-14 2025-06-30 13F ELEVANCE HEALTH COM 036752103 14,411 -810 -5.32 5,605 -15.33 0.0439
2025-05-07 2025-03-31 13F ELEVANCE HEALTH COM 036752103 15,221 -45,208 -74.81 6,621 -70.30 0.0592
2025-02-04 2024-12-31 13F ELEVANCE HEALTH COM 036752103 60,429 -41,211 -40.55 22,292 -57.82 0.1872
2024-11-19 2024-09-30 13F/A-1 ELEVANCE HEALTH COM 036752103 101,640 42,464 71.76 52,853 64.83 0.4621
2024-11-08 2024-09-30 13F ELEVANCE HEALTH COM 036752103 101,640 42,464 52,853 0.2376
2024-07-19 2024-06-30 13F ELEVANCE HEALTH COM 036752103 59,176 8,321 16.36 32,065 21.60 0.2866
2024-05-10 2024-03-31 13F ELEVANCE HEALTH COM 036752103 50,855 -859 -1.66 26,370 8.18 0.2670
2024-02-09 2023-12-31 13F ELEVANCE HEALTH COM 036752103 51,714 6,351 14.00 24,376 23.42 0.2716
2023-11-15 2023-09-30 13F ELEVANCE HEALTH COM 036752103 45,363 -2,251 -4.73 19,752 -6.63 0.2481
2023-08-14 2023-06-30 13F ELEVANCE HEALTH COM 036752103 47,614 -3,485 -6.82 21,154 -9.96 0.2346
2023-05-15 2023-03-31 13F ELEVANCE HEALTH COM 036752103 51,099 1,113 2.23 23,496 -8.37 0.3006
2023-02-14 2022-12-31 13F ELEVANCE HEALTH COM 036752103 49,986 -1,961 -3.78 25,641 8.66 0.3671
2022-10-27 2022-09-30 13F ELEVANCE HEALTH COM 036752103 51,947 466 0.91 23,597 -5.02 0.3452
2022-07-19 2022-06-30 13F ELEVANCE HEALTH COM 036752103 51,481 7 0.01 24,844 -1.74 0.3252
2022-04-19 2022-03-31 13F ANTHEM COM 036752103 51,474 3,937 8.28 25,285 14.75 0.2413
2022-01-26 2021-12-31 13F ANTHEM COM 036752103 47,537 34,224 257.07 22,035 343.99 0.1812
2021-10-26 2021-09-30 13F ANTHEM COM 036752103 13,313 692 5.48 4,963 2.99 0.0128
2021-07-23 2021-06-30 13F ANTHEM COM 036752103 12,621 -194 -1.51 4,819 4.76 0.0418
2021-05-05 2021-03-31 13F ANTHEM COM 036752103 12,815 12,815 4,600 0.0441
2018-02-09 2017-12-31 13F ANTHEM COM 036752103 0 -325,340 -100.00 0 -100.00
2017-11-06 2017-09-30 13F ANTHEM COM 036752103 325,340 -25,058 -7.15 61,776 -6.29 0.4910
2017-08-11 2017-06-30 13F ANTHEM COM 036752103 350,398 -47,375 -11.91 65,921 0.21 0.5474
2017-05-11 2017-03-31 13F ANTHEM COM 036752103 397,773 -68,413 -14.68 65,783 -1.85 0.5487
2017-02-10 2016-12-31 13F ANTHEM COM 036752103 466,186 -459,881 -49.66 67,024 -42.24 0.5045
2016-11-14 2016-09-30 13F ANTHEM COM 036752103 926,067 -52,157 -5.33 116,046 -9.68 0.8815
2016-08-12 2016-06-30 13F/A-1 ANTHEM COM 036752103 978,224 -56,879 -5.50 128,480 -10.70 0.9708
2016-08-11 2016-06-30 13F ANTHEM COM 036752103 978,224 128,480
2016-05-16 2016-03-31 13F ANTHEM COM 036752103 1,035,103 117,033 12.75 143,869 12.38 1.0552
2016-02-16 2015-12-31 13F ANTHEM COM 036752103 918,070 20,249 2.26 128,016 1.85 0.9192
2015-11-13 2015-09-30 13F ANTHEM COM 036752103 897,821 51,591 6.10 125,694 -9.51 0.9019
2015-08-12 2015-06-30 13F ANTHEM COM 036752103 846,230 -156,279 -15.59 138,900 -10.27 0.8945
2015-05-13 2015-03-31 13F ANTHEM COM 036752103 1,002,509 -119,779 -10.67 154,797 9.76 0.7431
2015-02-13 2014-12-31 13F ANTHEM COM 036752103 1,122,288 1,122,288 141,038 0.5900
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.